Is LCTX or LIMN more undervalued in 2026?

CirclFi compares Lineage Cell Therapeutics, Inc. (LCTX) and Liminatus Pharma, Inc. (LIMN) using 13 institutional-grade valuation models. LCTX has a Quality of Company score of 6.7/10 while LIMN scores 3.5/10.

Which is a better buy — LCTX or LIMN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do LCTX and LIMN valuations compare?

LCTX at $1.33 and LIMN at $0.18 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

LCTX vs LIMN Valuation Comparison 2026 — Intrinsic Value Analysis

LCTX

Biotechnology

Lineage Cell Therapeutics, Inc.

Quality

6.7

out of 10

Value Trap

SAFE

Price

$1.33

Last close

Models

9/13

Active

LIMN

Biotechnology

Liminatus Pharma, Inc.

Quality

3.5

out of 10

Value Trap

—

Price

$0.18

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	LCTX Fair Value	LCTX Upside	LIMN Fair Value	LIMN Upside
Bayesian DCF	Intrinsic	$0.34	-74.5%	$0.06	-67.7%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.23	-82.9%	$0.01	-92.8%
Dynamic NAV	Asset-Based	$0.24	-82.3%	$0.02	-87.1%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for LCTX vs LIMN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

LCTX vs LIMN — Which Stock Is More Undervalued?

LCTX scores higher with a 6.7/10 quality rating vs LIMN's 3.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Lineage Cell Therapeutics, Inc. (LCTX) and Liminatus Pharma, Inc. (LIMN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

LCTX currently trades at $1.33 with a QOC of 6.7/10, while LIMN trades at $0.18 with a QOC of 3.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).